journal article·2021-01Open access

Synthesis of gemifloxacin conjugated silver nanoparticles, their amplified bacterial efficacy against human pathogen and their morphological study via TEM analysis

Touqeer Ahmad, Fazal Mahbood, Rizwana Sarwar, Ayesha Iqbal, Majid Khan, Sayyar Muhammad, Khamis AL-Riyami, Nusrat Hussain, Jalal Uddin, Ajmal Khan, Ahmed Al-Harrasi

Abstract

Drug-loaded nanoparticles (NPs) allow specific accumulation and controlled release of drugs to infected tissues with minimal cytotoxicity. In this study, gemifloxacin conjugated silver nanoparticles (Gemi-AgNPs) were synthesized, and the amplification of their antibacterial potential against the human pathogen as well as their stability was monitored under physiological conditions. Fourier transform infrared spectroscopy (FTIR) analysis demonstrated the interaction between –NH2 and –OH functional moiety and the metal surface. The morphological analyses via transmission electron microscopy revealed that Gemi-AgNPs has a round oval shape and average particle size of 22.23 ± 2 nm. The antibacterial and antibiofilm activities of these NPS showed that Gemi-AgNPs exhibit excellent antimicrobial and biofilm inhibition activity against human pathogens, namely, Proteus mirabilis (P. mirabilis) and methicillin-resistant Staphylococcus aureus (MRSA). A significant increase in the antibiofilm activity of Gemi-AgNPs was confirmed by crystal violet, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) staining, and microscopic analysis. Gemi-AgNPs exhibited the ability to inhibit urease with an IC50 value of 57.4 ± 0.72 µg/mL. The changes in the bacterial cell morphology were analyzed via TEM, which revealed that cell membranes disrupted and completely destroyed the cell morphology by the treatment of Gemi-AgNPs.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticles: synthesis and applications · Advancements in Transdermal Drug Delivery · Bacterial biofilms and quorum sensing

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Natural and Medical Sciences Research Center, University of Nizwa, Nizwa, Oman

Institute of Chemical Sciences, University of Swat, KP, Pakistan

Department of Chemistry, COMSATS University Islamabad Abbottabad Campus, Abbottabad, Pakistan

Division of Pharmacy Practice and Policy, School of Pharmacy, University of Nottingham, Nottingham, UK

International Center for Chemical and Biological Sciences, H.E.J. Research Institute of Chemistry, University of Karachi, Karachi, Pakistan

Department of Chemistry, Islamia College, Peshawar, Pakistan

Department of Chemistry, University of Baltistan Skardu, Skardu, Pakistan

Department of Pharmaceutical Chemistry, College of Pharmacy, King Khalid University, Abha, Saudi Arabia

Funding

The Oman Research Council

References (54)

Show source-provided references
1. 10.1007/978-3-030-27874-8_110.1007/978-3-030-27874-8_1 ↗
2. 10.1016/j.toxlet.2007.10.00410.1016/j.toxlet.2007.10.004 ↗
3. 10.1002/wnan.158210.1002/wnan.1582 ↗
4. 10.1016/j.jconrel.2020.07.02110.1016/j.jconrel.2020.07.021 ↗
5. 10.1007/s10904-020-01744-x10.1007/s10904-020-01744-x ↗
6. 10.1016/B978-0-12-815726-8.00012-X10.1016/B978-0-12-815726-8.00012-X ↗
7. Contera S. Nano comes to life: how nanotechnology is transforming medicine and the future of biology. Princeton, United States: Princeton University Press; 2019.
8. 10.1007/s13204-020-01268-310.1007/s13204-020-01268-3 ↗
9. 10.1016/j.jaap.2020.10484010.1016/j.jaap.2020.104840 ↗
10. 10.5772/intechopen.9373410.5772/intechopen.93734 ↗
11. 10.3390/ani1107191610.3390/ani11071916 ↗
12. 10.1016/j.cis.2020.10224610.1016/j.cis.2020.102246 ↗
13. 10.1002/adma.20200212910.1002/adma.202002129 ↗
14. 10.1038/s41579-020-0420-110.1038/s41579-020-0420-1 ↗
15. 10.3390/ijms2215794810.3390/ijms22157948 ↗
16. 10.1021/acsomega.0c0158110.1021/acsomega.0c01581 ↗
17. 10.1080/10408398.2020.179372410.1080/10408398.2020.1793724 ↗
18. 10.1038/s41598-020-68290-x10.1038/s41598-020-68290-x ↗
19. 10.1007/s00436-020-06694-410.1007/s00436-020-06694-4 ↗
20. 10.1016/j.bioorg.2021.10511610.1016/j.bioorg.2021.105116 ↗
21. 10.1080/21691401.2021.189919310.1080/21691401.2021.1899193 ↗
22. 10.1080/21691401.2018.153606010.1080/21691401.2018.1536060 ↗
23. 10.1002/pca.274310.1002/pca.2743 ↗
24. 10.1016/j.ijbiomac.2015.04.03210.1016/j.ijbiomac.2015.04.032 ↗
25. 10.1016/j.nano.2009.04.00610.1016/j.nano.2009.04.006 ↗
26. 10.1021/acsnano.7b0124010.1021/acsnano.7b01240 ↗
27. 10.1002/jbm.a.3708610.1002/jbm.a.37086 ↗
28. 10.1016/j.bioorg.2020.10423110.1016/j.bioorg.2020.104231 ↗
29. 10.1088/0957-4484/16/9/08210.1088/0957-4484/16/9/082 ↗
30. 10.1080/10590501.2015.105516510.1080/10590501.2015.1055165 ↗
31. 10.1155/2020/132409610.1155/2020/1324096 ↗
32. 10.3390/pharmaceutics1308128910.3390/pharmaceutics13081289 ↗
33. 10.1136/gut.45.2008.ii4310.1136/gut.45.2008.ii43 ↗
34. 10.1093/jac/44.6.83510.1093/jac/44.6.835 ↗
35. 10.1371/journal.pone.023798710.1371/journal.pone.0237987 ↗
36. 10.1016/j.scitotenv.2020.14153810.1016/j.scitotenv.2020.141538 ↗
37. 10.1523/JNEUROSCI.19-02-00529.199910.1523/JNEUROSCI.19-02-00529.1999 ↗
38. 10.1128/AAC.41.1.20410.1128/AAC.41.1.204 ↗
39. 10.2147/IJN.S19819410.2147/IJN.S198194 ↗
40. 10.1016/j.jksus.2016.12.00810.1016/j.jksus.2016.12.008 ↗
41. 10.1016/j.ejmech.2017.06.06510.1016/j.ejmech.2017.06.065 ↗
42. 10.1016/j.micpath.2016.06.01610.1016/j.micpath.2016.06.016 ↗
43. 10.1021/ac60252a04510.1021/ac60252a045 ↗
44. 10.1021/acs.nanolett.0c0332910.1021/acs.nanolett.0c03329 ↗
45. 10.1039/D0SC04651E10.1039/D0SC04651E ↗
46. 10.1021/jp984796o10.1021/jp984796o ↗
47. 10.2147/IJN.S14619510.2147/IJN.S146195 ↗
48. 10.1099/jmm.0.00043010.1099/jmm.0.000430 ↗
49. 10.1007/s12602-020-09689-w10.1007/s12602-020-09689-w ↗
50. 10.1128/IAI.00652-2010.1128/IAI.00652-20 ↗
51. 10.1128/AAC.00124-1010.1128/AAC.00124-10 ↗
52. 10.2147/IJN.S23223010.2147/IJN.S232230 ↗
53. 10.1590/fst.3201810.1590/fst.32018 ↗
54. 10.1128/AAC.49.10.4085-4092.200510.1128/AAC.49.10.4085-4092.2005 ↗